# tDCS and Speech Therapy to Improve Aphasia

> **NCT02395874** · NA · UNKNOWN · sponsor: **Medical Park AG** · enrollment: 96 (estimated)

## Conditions studied

- Aphasia, Global
- Stroke
- Transcranial Direct Current Stimulation
- Speech Therapy

## Interventions

- **PROCEDURE:** tDCS + speech therapy

## Key facts

- **NCT ID:** NCT02395874
- **Lead sponsor:** Medical Park AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2018-04
- **Final completion:** 2018-10
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2016-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02395874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02395874, "tDCS and Speech Therapy to Improve Aphasia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02395874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*